Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer
- 27 October 2010
- journal article
- gastrointestinal
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 21 (5), 987-995
- https://doi.org/10.1007/s00330-010-1989-y
Abstract
Objective To determine whether change in the apparent diffusion coefficient (ADC) before and after neoadjuvant chemoradiation therapy (CRT) for locally advanced rectal cancer (LARC) would more accurately predict pathological complete response (pCR) than analysing the pre- or post-CRT ADC individually. Methods 76 patients with LARC (≥T3 or lymph node-positive) underwent pre- and post-CRT, 1.5-T diffusion-weighted imaging. A blinded radiologist measured the tumour ADCs. The three measures were compared with regard to CR and non-CR. To calculate accuracy for determining pCR, receiver-operating characteristic curve (ROC) analysis was applied to the three measures. Results The post-CRT ADC (1.43 ± 0.10) (×10−3 mm2/s) and the percentage change (70.0 ± 23.5%) in the CR (n = 11) were significantly higher than those in the non-CR (n = 65) (1.14 ± 0.18, 30.2 ± 21.7%, respectively)(both, P < 0.0001). The pre-CRT ADC (0.85 ± 0.10) of the pCR did not differ significantly from that of the non-pCR (0.88 ± 0.14)(P = 0.4094). The post-CRT ADC showed comparable relative accuracy for determining pCR to that of the percentage change (P = 0.788). However, overall accuracy of the former (87%) was higher than that of the latter (75%) (P = 0.049). Conclusion Analyzing post-CRT ADC alone can reliably differentiate pCR from non-pCR in LARCKeywords
This publication has 37 references indexed in Scilit:
- Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancerJournal of Magnetic Resonance Imaging, 2009
- Diagnostic Accuracy of 3.0-Tesla Rectal Magnetic Resonance Imaging in Preoperative Local Staging of Primary Rectal CancerInvestigative Radiology, 2008
- Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapyNature Clinical Practice Oncology, 2008
- Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal CancerAnnals of Surgical Oncology, 2007
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Diffusion-weighted MRI: a new functional clinical technique for tumour imagingThe British Journal of Radiology, 2006
- A Pathologic Complete Response of Rectal Cancer to Preoperative Combined-Modality Therapy Results in Improved Oncological Outcome Compared With Those Who Achieve No Downstaging on the Basis of Preoperative Endorectal UltrasonographyAnnals of Surgical Oncology, 2006
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Response to Preoperative Chemoradiation in Stage II and III Rectal CancerDiseases of the Colon & Rectum, 2003
- A Pathologic Complete Response to Preoperative Chemoradiation Is Associated With Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal ExcisionDiseases of the Colon & Rectum, 2003